- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 317/12 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
Patent holdings for IPC class C07D 317/12
Total number of patents in this class: 110
10-year publication summary
|
6
|
5
|
7
|
3
|
8
|
10
|
5
|
3
|
5
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Eastman Chemical Company | 2087 |
10 |
| Firmenich SA | 1760 |
8 |
| BASF SE | 21303 |
4 |
| DSM IP Assets B.V. | 5379 |
4 |
| Kolon Plastics, Inc. | 41 |
4 |
| Segetis, Inc. | 38 |
4 |
| V. Mane Fils | 175 |
4 |
| Shell Internationale Research Maatschappij B.V. | 3403 |
3 |
| Council of Scientific & Industrial Research | 1445 |
3 |
| Vertex Pharmaceuticals Incorporated | 1582 |
2 |
| ENI S.p.A. | 1305 |
2 |
| Gilead Sciences, Inc. | 2222 |
2 |
| Ishihara Sangyo Kaisha, Ltd. | 659 |
2 |
| Kuraray Co., Ltd. | 3589 |
2 |
| University of Newcastle upon Tyne | 243 |
2 |
| RinuaGene Biotechnology Co., Ltd. | 37 |
2 |
| Rinuagene International HK Limited | 35 |
2 |
| The Procter & Gamble Company | 21855 |
1 |
| Bristol-myers Squibb Company | 4742 |
1 |
| F. Hoffmann-La Roche AG | 7837 |
1 |
| Other owners | 47 |